Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOD1 | Q9Y239 | 2/20 | 0.42 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.39 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.39 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.39 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.39 |
| ▸ | SOAT1 | P35610 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | FAAH | O00519 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.37 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.37 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.37 |
| ▸ | CNR1 | P21554 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5495880 | 1.00 | NOD1 (0.42) | NOD1GRIK1GRIK2SLC1A2SLC1A1 | |
| SCHEMBL8019482 | 0.89 | AKR1B1 (0.44) | NOD1KMT2AALOX15MEN1GPR84 | |
| SCHEMBL8633798 | 0.88 | KMT2A (0.42) | NOD1GRIK1GRIK2SLC1A2SLC1A1 | |
| SCHEMBL27812063 | 0.84 | NOD1 (0.57) | NOD1GRIK1GRIK2SLC1A2SLC1A1 | |
| SCHEMBL6890621 | 0.84 | NOD1 (0.57) | NOD1GRIK1GRIK2SLC1A2SLC1A1 | |
| SCHEMBL1267741 | 0.84 | NOD1 (0.42) | NOD1GRIK1GRIK2SLC1A2SLC1A1 | |
| SCHEMBL29245602 | 0.84 | NOD1 (0.57) | NOD1GRIK1GRIK2SLC1A2SLC1A1 | |
| SCHEMBL30985279 | 0.84 | NOD1 (0.57) | NOD1GRIK1GRIK2SLC1A2SLC1A1 | |
| SCHEMBL4541605 | 0.84 | NOD1 (0.42) | NOD1GRIK1GRIK2SLC1A2SLC1A1 | |
| SCHEMBL2380903 | 0.83 | NOD1 (0.40) | NOD1GRIK1GRIK2SLC1A2SLC1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110506853-A | Application of the N- glycyl glutamine in animal feed additive | GUANGZHOU INSIGHTER BIOTECHNOLOGY CO LTD | 2019-11-29 | — | — | CN | claimed |
| CN-109652376-A | A kind of culture medium for ovarian cancer tissue 3D culture | 创芯国际生物科技(广州)有限公司 | 2019-04-19 | — | — | CN | claimed |
| CN-110229784-A | A method of it removing the separating liquid of dead liver cell and removes dead liver cell using it | 立沃生物科技（深圳）有限公司 | 2019-09-13 | — | — | CN | disclosed |
| CN-109771370-A | A kind of intraocular surgery Anterior chamber irrigating solution and application thereof | 厦门大学 | 2019-05-21 | — | — | CN | disclosed |
| CN-109642213-A | Phase transfer with loaded scaffold | 牛津大学创新有限公司 | 2019-04-16 | — | — | CN | disclosed |
| CN-109562091-A | For retaining, improving or restoring the glutamine of renal function | 费森尤斯卡比德国有限公司 | 2019-04-02 | — | — | CN | disclosed |
| CN-109486883-A | A method of preparing Ala-Gln | 广东驱动力生物科技股份有限公司 | 2019-03-19 | — | — | CN | disclosed |
| CN-109477071-A | The 3D printing of cellularised bracket | 牛津大学创新有限公司 | 2019-03-15 | — | — | CN | disclosed |
| CN-109414494-A | Method for producing virus | 基准动物健康有限公司 | 2019-03-01 | — | — | CN | disclosed |
| CN-109295090-A | A kind of application of cell cycle regulating protein CREPT in the maintenance of animal embryonic stem cell versatility | 清华大学 | 2019-02-01 | — | — | CN | disclosed |
| CN-105125497-B | A kind of preparation method of N (2)-Ala-Gln injection | 南京恩泰医药科技有限公司 | 2018-11-20 | — | — | CN | disclosed |
| CN-108699529-A | Chemically-defined media for culturing cell populations comprising Cancer Stem Cells (CSCs) | 普乐思尔活性生物科学有限公司 | 2018-10-23 | — | — | CN | disclosed |
| CN-108210879-A | A kind of pharmaceutical composition for treating acute Cerebral bleeding and its application | 张海峰 | 2018-06-29 | — | — | CN | disclosed |
| CN-108159391-A | The composition of honey and Ala-Gln | 本尼诺克斯有限公司 | 2018-06-15 | — | — | CN | disclosed |
| CN-105101984-B | Ala-Gln, hyaluronic acid and oat extract synergistic combination and its for healing of wound and repair skin injury composition in purposes | 皮埃尔·法布尔皮肤化妆品公司 | 2018-06-01 | — | — | CN | disclosed |
| CN-101151369-B | Dipeptide crystals and process for production thereof | 协和发酵生化株式会社 | 2017-02-15 | — | — | CN | disclosed |
| US-20070197430-A1 | Conjugates And Therapeutic Uses Thereof | THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH (AU) | 2007-08-23 | — | — | US | disclosed |
| EP-1781689-A1 | CONJUGATES AND THERAPEUTIC USES THEREOF | The Walter and Eliza Hall Institute of Medical Research (AU) | 2007-05-09 | — | — | EP | disclosed |
| WO-2006000034-A1 | CONJUGATES AND THERAPEUTIC USES THEREOF | THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH (AU) | 2006-01-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070197430-A1 | Conjugates And Therapeutic Uses Thereof | BCL2, BAX, BAD | NOD1 3706/4885GRIK1 3638/4885GRIK2 2927/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.